Abstract
With a view to the rational design of selective quinoxaline derivatives, 2D and 3D-QSAR models have been developed for the prediction of anti-tubercular activities. Successful implementation of a predictive QSAR model largely depends on the selection of a preferred set of molecular descriptors that can signify the chemico – biological interaction. Genetic algorithm (GA) and simulated annealing (SA) are applied as variable selection methods for model development. 2D-QSAR modeling using GA or SA based partial least squares (GA-PLS and SA-PLS) methods identified some important topological and electrostatic descriptors as important factor for tubercular activity. Kohonen network and counter propagation artificial neural network (CP-ANN) considering GA and SA based feature selection methods have been applied for such QSAR modeling of Quinoxaline compounds. Out of a variable pool of 380 molecular descriptors, predictive QSAR models are developed for the training set and validated on the test set compounds and a comparative study of the relative effectiveness of linear and non-linear approaches has been investigated. Further analysis using 3D-QSAR technique identifies two models obtained by GA-PLS and SA-PLS methods leading to anti-tubercular activity prediction. The influences of steric and electrostatic field effects generated by the contribution plots are discussed. The results indicate that SA is a very effective variable selection approach for such 3D-QSAR modeling.
Keywords: Quinoxaline derivatives, Quantitative Structure Activity Relationship (QSAR), 2D and 3D descriptors, genetic algorithm (GA), simulated annealing (SA), Partial Least Squares (PLS), counter propagation artificial neural network (CP-ANN)
Current Medicinal Chemistry
Title: QSAR Modeling for Quinoxaline Derivatives using Genetic Algorithm and Simulated Annealing Based Feature Selection
Volume: 16 Issue: 30
Author(s): P. Ghosh and M. C. Bagchi
Affiliation:
Keywords: Quinoxaline derivatives, Quantitative Structure Activity Relationship (QSAR), 2D and 3D descriptors, genetic algorithm (GA), simulated annealing (SA), Partial Least Squares (PLS), counter propagation artificial neural network (CP-ANN)
Abstract: With a view to the rational design of selective quinoxaline derivatives, 2D and 3D-QSAR models have been developed for the prediction of anti-tubercular activities. Successful implementation of a predictive QSAR model largely depends on the selection of a preferred set of molecular descriptors that can signify the chemico – biological interaction. Genetic algorithm (GA) and simulated annealing (SA) are applied as variable selection methods for model development. 2D-QSAR modeling using GA or SA based partial least squares (GA-PLS and SA-PLS) methods identified some important topological and electrostatic descriptors as important factor for tubercular activity. Kohonen network and counter propagation artificial neural network (CP-ANN) considering GA and SA based feature selection methods have been applied for such QSAR modeling of Quinoxaline compounds. Out of a variable pool of 380 molecular descriptors, predictive QSAR models are developed for the training set and validated on the test set compounds and a comparative study of the relative effectiveness of linear and non-linear approaches has been investigated. Further analysis using 3D-QSAR technique identifies two models obtained by GA-PLS and SA-PLS methods leading to anti-tubercular activity prediction. The influences of steric and electrostatic field effects generated by the contribution plots are discussed. The results indicate that SA is a very effective variable selection approach for such 3D-QSAR modeling.
Export Options
About this article
Cite this article as:
Ghosh P. and Bagchi C. M., QSAR Modeling for Quinoxaline Derivatives using Genetic Algorithm and Simulated Annealing Based Feature Selection, Current Medicinal Chemistry 2009; 16 (30) . https://dx.doi.org/10.2174/092986709789352303
DOI https://dx.doi.org/10.2174/092986709789352303 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gold and Silver Nanoparticles for Applications in Theranostics
Current Topics in Medicinal Chemistry Antitubercular Marine Natural Products
Current Medicinal Chemistry Preface
Current Drug Targets - Infectious Disorders Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection
Current Immunology Reviews (Discontinued) IO Nation: The Rise of Immuno-Oncology
Current Pharmacogenomics and Personalized Medicine MIANN Models in Medicinal, Physical and Organic Chemistry
Current Topics in Medicinal Chemistry Editorial (Mucosal Co-Infections and HIV-1 Transmission and Pathogenesis)
Current HIV Research Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector
Current HIV Research Amyloidosis and Auto-Inflammatory Syndromes
Current Drug Targets - Inflammation & Allergy Obesity and the Aging Respiratory System
Current Respiratory Medicine Reviews A Novel Advanced Laboratory Diagnosis to Guide Tuberculosis Drug Therapy.
Recent Patents on Anti-Infective Drug Discovery Nanochemistry-Based Immunotherapy for HIV-1
Current Medicinal Chemistry A Study on the Biological Activity of 2-thioxo-imidazolidin-4-ones
Letters in Drug Design & Discovery Biological and Chemical Diversity of Coral-Derived Microorganisms
Current Medicinal Chemistry Strategies for the Biological Evaluation of Gold Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis
Current HIV Research Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Recent Advances in Design of Glycogen Phosphorylase Inhibitors
Current Enzyme Inhibition Analysis of DNA Microarray Data
Current Topics in Medicinal Chemistry